These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1837507)

  • 21. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
    Bergerot I; Souchier C; Thivolet C
    C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-islet Cell Antibodies in a Sample of Egyptian Females with Gestational Diabetes and its Relation to Development of Type 1 Diabetes Mellitus.
    Amer HM; Abd El Baky RS; Nasr MS; Hendawy LM; Ibrahim WA; Taha MO
    Curr Diabetes Rev; 2018; 14(4):389-394. PubMed ID: 28464768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence against an immunogenetic basis for diabetes in chronic pancreatitis.
    Colman PG; Begley CG; Tait BD; Roberts-Thomson IC; Harrison LC
    Aust N Z J Med; 1987 Aug; 17(4):392-5. PubMed ID: 3325010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.
    Thivolet C; Beaufrére B; Bétuel H; Gebuhrer L; Chatelain P; Durand A; Tourniaire J; François R
    Diabetologia; 1988 Oct; 31(10):741-6. PubMed ID: 3071483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets. The Belgian Diabetes Registry.
    Gorus FK; Sodoyez JC; Pipeleers DG; Keymeulen B; Foriers A; Van Schravendijk CF
    Diabetologia; 1992 Nov; 35(11):1080-6. PubMed ID: 1473619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.
    Bingley PJ
    Diabetes; 1996 Dec; 45(12):1720-8. PubMed ID: 8922357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Islet cell surface antibodies in diabetes and their possible influence on glucose tolerance.
    Ohgawara H; Hirata Y
    Tohoku J Exp Med; 1984 Feb; 142(2):211-6. PubMed ID: 6372161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus: beta-cell function, islet cell antibody, and haptoglobin in parents of IDDM patients.
    Kajio H; Kobayashi T; Nakanishi K; Okubo M; Tsukada T; Nakayama T; Yamada N; Murase T; Yazaki Y; Kosaka K
    Metabolism; 1995 Jul; 44(7):869-75. PubMed ID: 7616845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population based study of prevalence of islet cell autoantibodies in monozygotic and dizygotic Danish twin pairs with insulin dependent diabetes mellitus.
    Petersen JS; Kyvik KO; Bingley PJ; Gale EA; Green A; Dyrberg T; Beck-Nielsen H
    BMJ; 1997 May; 314(7094):1575-9. PubMed ID: 9169400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of incidental hyperglycemia and glycosuria of childhood.
    Schatz DA; Kowa H; Winter WE; Riley WJ
    J Pediatr; 1989 Nov; 115(5 Pt 1):676-80. PubMed ID: 2681635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.
    Turner R; Stratton I; Horton V; Manley S; Zimmet P; Mackay IR; Shattock M; Bottazzo GF; Holman R
    Lancet; 1997 Nov; 350(9087):1288-93. PubMed ID: 9357409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The detection of autoantibodies to pancreatic islet cells by immunoenzyme histochemistry.
    Kohnert KD; Rjasanowski I; Hehmke B; Hamann J; Keilacker H; Michaelis D
    Diabetes Res; 1994; 25(1):1-12. PubMed ID: 7648777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity.
    Williams AJ; Norcross AJ; Lock RJ; Unsworth DJ; Gale EA; Bingley PJ
    Diabetes Care; 2001 Mar; 24(3):504-9. PubMed ID: 11289476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children.
    Landin-Olsson M; Karlsson A; Dahlquist G; Blom L; Lernmark A; Sundkvist G
    Diabetologia; 1989 Jun; 32(6):387-95. PubMed ID: 2547682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus.
    Kobayashi T; Nakanishi K; Kajio H; Morinaga S; Sugimoto T; Murase T; Kosaka K
    Diabetologia; 1990 Jun; 33(6):363-70. PubMed ID: 1696227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of various types of islet cell antibodies in diabetes as a function of its cause and duration].
    Vialettes B; Di Campo-Rougerie C; Lassmann V; Vague P
    Presse Med; 1983 Oct; 12(37):2303-6. PubMed ID: 6226978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes.
    Pietropaolo M; Barinas-Mitchell E; Pietropaolo SL; Kuller LH; Trucco M
    Diabetes; 2000 Jan; 49(1):32-8. PubMed ID: 10615947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.
    Seissler J; Morgenthaler NG; Achenbach P; Lampeter EF; Glawe D; Payton M; Christie M; Scherbaum WA
    Diabetologia; 1996 Nov; 39(11):1351-6. PubMed ID: 8933004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.